Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Immutep (IMMP) has a market cap of $0.23 billion USD. According to our data, Immutep is ranked No.6843 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $0.23 B |
-27.86%
|
| Dec 31, 2024 | $0.32 B |
-9.58%
|
| Dec 29, 2023 | $0.35 B |
37.14%
|
| Dec 30, 2022 | $0.25 B |
-46.65%
|
| Dec 31, 2021 | $0.48 B |
4.46%
|
| Dec 31, 2020 | $0.46 B |
75.42%
|
| Dec 31, 2019 | $0.26 B |
-2.72%
|
| Dec 31, 2018 | $0.27 B |
17.20%
|
| Dec 29, 2017 | $0.23 B |
-32.91%
|
| Dec 30, 2016 | $0.34 B |
-38.42%
|
| Dec 31, 2015 | $0.55 B |
70.15%
|
| Dec 31, 2014 | $0.32 B |
-39.09%
|
| Dec 31, 2013 | $0.53 B |
-67.93%
|
| Dec 31, 2012 | $1.66 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
 Incyte
INCY
|
$11.31 B |
0.000 M
|
USA
|
| Market Cap | = | IMMP Stock Price | * | IMMP Shares Outstanding |
| = | $1.51 | * | 0.15 B | |
| = | $0.23 B |